Today
Options
Show Hide Related Items >> <<
06:18 Today Amgen announces Humira biosimilar now available in the U.S. 01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 01/03/23 Researchers' reanalysis questions mortality data in FOURIER trial 12/13/22 Amgen announces presentation of results from E1910 randomized Phase 3 trial 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/03/23 Barclays Research raises 'valid questions' about Amgen's Repatha, says Barclays 12/13/22 BMO Capital Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital 12/13/22 Baird Amgen deal yields nice accretion but large debt position, says Baird 13:20 Today Notable companies reporting after market close 11/03/22 Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00 11/03/22 Amgen reports Q3 adjusted EPS $4.70, consensus $4.44 11/03/22 Notable companies reporting after market close 06:26 Today AbbVie's Humira drug faces competition in the U.S., FT reports 01/30/23 Amgen lays off 300 employees, or 1.2% of workforce, Reuters reports 01/26/23 Warren writes FTC over concerns of two pharma deals, Reuters reports 12/11/22 Amgen nears deal to acquire Horizon Therapeutics, WSJ reports 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 What You Missed On Wall Street On Monday 10/11/22 Early notable gainers among liquid option names on October 11th
Recommendations
Show Hide Related Items >> <<
14:02 Today Workday to eliminate about 3% of global workforce in realignment 01/29/23 Fly Intel: Top five weekend stock stories 12/20/22 Workday appoints Carl Eschenbach as co-CEO 11/29/22 Workday sees FY24 subscription revenue growth of 17%-19% to $6.5B-$6.6B 01/23/23 Deutsche Bank Workday downgraded to Hold from Buy at Deutsche Bank 01/17/23 Guggenheim Workday downgraded to Sell from Neutral at Guggenheim 01/13/23 Capital One Workday initiated with an Overweight at Capital One 01/09/23 MoffettNathanson Workday initiated with an Outperform at MoffettNathanson 11/29/22 Workday raises low end of FY23 subscription revenue to $5.555B-$5.557B 11/29/22 Workday reports Q3 adjusted EPS 99c, consensus 84c 11/29/22 Notable companies reporting after market close 08/25/22 Workday still sees FY23 suscription revenue up 22% y-o-y to $5.54B-$5.56B 01/28/23 Workday is software stock to own now, Barron's says 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/14/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/26/23 Workday call volume above normal and directionally bullish 01/05/23 Workday put volume heavy and directionally bearish 12/19/22 Workday call volume above normal and directionally bullish 11/29/22 Workday options imply 7.8% move in share price post-earnings
Hot Stocks
Show Hide Related Items >> <<
01/29/23 Fly Intel: Top five weekend stock stories 12/20/22 Workday appoints Carl Eschenbach as co-CEO 11/29/22 Workday sees FY24 subscription revenue growth of 17%-19% to $6.5B-$6.6B 11/29/22 Workday jumps 5% to $150.00 after Q3 results beat estimates 01/23/23 Deutsche Bank Workday downgraded to Hold from Buy at Deutsche Bank 01/17/23 Guggenheim Workday downgraded to Sell from Neutral at Guggenheim 01/13/23 Capital One Workday initiated with an Overweight at Capital One 01/09/23 MoffettNathanson Workday initiated with an Outperform at MoffettNathanson 11/29/22 Workday raises low end of FY23 subscription revenue to $5.555B-$5.557B 11/29/22 Workday reports Q3 adjusted EPS 99c, consensus 84c 11/29/22 Notable companies reporting after market close 08/25/22 Workday still sees FY23 suscription revenue up 22% y-o-y to $5.54B-$5.56B 01/28/23 Workday is software stock to own now, Barron's says 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/14/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/26/23 Workday call volume above normal and directionally bullish 01/05/23 Workday put volume heavy and directionally bearish 12/19/22 Workday call volume above normal and directionally bullish 11/29/22 Workday options imply 7.8% move in share price post-earnings
Earnings
Notable companies…
Notable companies reporting after the market close, with earnings consensus, include Amgen (AMGN), consensus $4.09... AMD (AMD), consensus 67c... Mondelez (MDLZ), consensus 70c... Edward Lifesciences (EW), consensus 61c... Electronic Arts (EA), consensus $3.05... Snap (SNAP), consensus 11c... Match Group (MTCH), consensus 46c... Western Digital (WDC), consensus (12c)... Juniper Networks (JNPR), consensus 65c.
Show Hide Related Items >> <<
06:18 Today Amgen announces Humira biosimilar now available in the U.S. 01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 01/03/23 Researchers' reanalysis questions mortality data in FOURIER trial 12/13/22 Amgen announces presentation of results from E1910 randomized Phase 3 trial 01/20/23 AMD identified as respondent in ITC investigation of certain integrated circuits 01/19/23 AMD adaptive computing tech enables DENSO LiDAR system 01/11/23 AMD CFO Devinder Kumar to retire, Jean Hu appointed new CFO 12/20/22 EU opens antitrust probe into Broadcom's proposed $61B VMware bid 01/23/23 Enthusiast Gaming announces partnership with Mondelez's SOUR PATCH KIDS 01/19/23 Mondelez releases fourth annual State of Snacking report 01/09/23 Mondelez to release special edition Oreos with Xbox images 12/19/22 Mondelez to sell developed-market gum business to Perfetti Van Melle for $1.35B 12/08/22 Edwards Lifesciences CEO Michael Mussallem to retire, Bernard Zovighian succeeds 11/01/22 Edwards Lifesciences authorizes $750M accelerated share repurchase 10/28/22 Edwards Lifesciences falls -16.6% 10/28/22 Edwards Lifesciences falls -14.3% 01/19/23 Sony announces additional games coming to PlayStation VR2 01/17/23 U.S. video game consumer spending rose 2% y/y in December, says NPD 01/17/23 'Call of Duty: Modern Warfare 2' top game seller in U.S. in December, says NPD 11/21/22 Electronic Arts CEO Wilson sells 10,000 common shares 01/08/23 Fly Intel: Top five weekend stock stories 01/06/23 Snap to shut down Camera app on January 25 12/15/22 Snap falls -6.7% 12/13/22 Rubio, Gallagher introduce bipartisan legislation to ban TikTok 01/26/23 Match Group names executive leadership team 12/13/22 Match Group up 8% after Bloomberg report on Apple App store plans 11/20/22 Fly Intel: Top five weekend stock stories 09/29/22 Match Group names Linda Kim as COO of Hyperconnect 10/26/22 Kioxia, Western Digital open semiconductor fabrication facility Fab7 in Japan 08/31/22 Western Digital, Micron lower in pre-market after Seagate guidance cut 08/15/22 Elliott buys Pinterest, exits Twitter in Q2 08/05/22 Western Digital drops 8% to $45.80 after Q1 guidance misses estimates 12/12/22 Juniper selected as preferred technology partner for Deutsche Telekom's SD-X 12/07/22 Juniper CEO sells $604K in common stock 10/28/22 Juniper director Kriens sells 140,000 common shares 10/13/22 Juniper appoints Chris Kaddaras as chief revenue officer 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/03/23 Barclays Research raises 'valid questions' about Amgen's Repatha, says Barclays 12/13/22 BMO Capital Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital 12/13/22 Baird Amgen deal yields nice accretion but large debt position, says Baird 01/30/23 Morgan Stanley Intel's quarter points to some risk for AMD in Q1, says Morgan Stanley 01/30/23 Susquehanna AMD price target raised to $88 from $80 at Susquehanna 01/27/23 BofA Intel price target lowered to $25 from $28 at BofA 01/27/23 Barclays Intel price target lowered to $27 from $30 at Barclays 01/06/23 Mizuho Mondelez price target raised to $78 from $75 at Mizuho 01/03/23 Wells Fargo Mondelez initiated with an Overweight at Wells Fargo 01/03/23 RBC Capital Mondelez downgraded to Sector Perform from Outperform at RBC Capital 12/20/22 Morgan Stanley Mondelez price target raised to $75 from $69 at Morgan Stanley 07:37 Today Bernstein Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein 01/30/23 Piper Sandler Edwards Lifesciences downgraded to Neutral from Overweight at Piper Sandler 12/12/22 Canaccord Edwards Lifesciences price target lowered to $73 from $78 at Canaccord 12/12/22 Citi Edwards Lifesciences price target lowered to $92 from $99 at Citi 01/27/23 Wedbush Electronic Arts initiated with an Outperform at Wedbush 01/27/23 Credit Suisse Electronic Arts price target raised to $154 from $143 at Credit Suisse 01/25/23 Barclays Electronic Arts price target raised to $132 from $130 at Barclays 01/17/23 Benchmark Electronic Arts price target lowered to $150 from $188 at Benchmark 01/20/23 MKM Partners MKM Partners cuts Pinterest to Neutral, sees balanced risk-reward 01/19/23 JPMorgan JPMorgan calls out Meta as top pick ahead of earnings from online ads group 01/18/23 OTR Global Snap downgraded to Mixed from Positive view at OTR Global 01/17/23 JMP Securities Snap downgraded to Market Perform from Outperform at JMP Securities 01/30/23 Deutsche Bank Match Group price target raised to $65 from $60 at Deutsche Bank 01/26/23 Citi Match Group initiated with a Neutral at Citi 01/25/23 Barclays Match Group price target raised to $52 from $50 at Barclays 01/24/23 Jefferies Match Group, Bumble price targets raised at Jefferies ahead of earnings 01/23/23 Exane BNP Paribas Western Digital upgraded to Neutral from Underperform at Exane BNP Paribas 01/06/23 Benchmark Western Digital upgraded to Hold at Benchmark after Kioxia merger talks report 01/06/23 Benchmark Western Digital upgraded to Hold from Sell at Benchmark 01/05/23 Deutsche Bank Western Digital, Kioxia deal makes 'a lot of sense,' says Deutsche Bank 01/17/23 Piper Sandler Juniper price target raised to $32 from $31 at Piper Sandler 12/20/22 JPMorgan JPMorgan ups Juniper target, adds to Analyst Focus List 12/13/22 Morgan Stanley Juniper price target raised to $29 from $25 at Morgan Stanley 10/26/22 Piper Sandler Juniper price target raised to $31 from $29 at Piper Sandler 11/03/22 Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00 11/03/22 Amgen reports Q3 adjusted EPS $4.70, consensus $4.44 11/03/22 Notable companies reporting after market close 08/04/22 Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40 11/01/22 AMD cuts FY22 revenue view to $23.5B +/- $300M from $26.3B +/- $300M 11/01/22 AMD sees Q4 revenue $5.5B +/- $300M, consensus $5.85B 11/01/22 AMD reports Q3 EPS 67c, consensus 68c 11/01/22 Notable companies reporting after market close 11/01/22 Mondelez raises FY22 adjusted EPS view to 10% from up mid-to-high single digits 11/01/22 Mondelez reports Q3 adjusted EPS 74c, consensus 69c 11/01/22 Notable companies reporting after market close 01/10/23 Edwards Lifesciences not reaffirming Q4, 2023 guidance 12/08/22 Edwards Lifesciences backs FY22 adjusted EPS view $2.40-$2.50, consensus $2.46 12/08/22 Edwards Lifesciences sees FY23 adjusted EPS $2.45-$2.60, consensus $2.53 10/27/22 Edwards Lifesciences sees FY22 adjusted EPS $2.40-$2.50, consensus $2.51 11/01/22 Electronic Arts raises FY23 EPS view to $3.11-$3.34 from $2.79-$2.87 11/01/22 Electronic Arts sees Q3 EPS 43c-59c, consensus $3.01 11/01/22 Electronic Arts reports Q2 EPS $1.07, consensus $1.37 11/01/22 Notable companies reporting after market close 10/20/22 Snap reports Q3 adjusted EPS 8c, consensus (1c) 10/20/22 Notable companies reporting after market close 08/31/22 Snap says forward looking revenue visibility 'remains limited' 08/31/22 Snap sees Q3 revenue growth at 8% through August 29 11/01/22 Match Group sees 2023 revenue growth 5%-10% 11/01/22 Match Group sees Q4 revenue $780M-$790M, consensus $810.35M 11/01/22 Match Group reports Q3 EPS 44c, consensus 51c 11/01/22 Notable companies reporting after market close 10/27/22 Western Digital sees Q2 EPS (25c)-5c, consensus 34c 10/27/22 Western Digital reports Q1 EPS 20c, consensus 39c 08/05/22 Western Digital sees Q1 EPS 35c-65c, consensus $1.96 08/05/22 Western Digital reports Q4 EPS $1.78, consensus $1.68 10/25/22 Juniper Networks sees Q4 adjusted EPS 64c, plus or minus 5c, consensus 62c 10/25/22 Juniper Networks reports preliminary Q3 adjusted EPS 58c, consensus 50c 10/25/22 Notable companies reporting after market close 06:26 Today AbbVie's Humira drug faces competition in the U.S., FT reports 01/30/23 Amgen lays off 300 employees, or 1.2% of workforce, Reuters reports 01/26/23 Warren writes FTC over concerns of two pharma deals, Reuters reports 12/11/22 Amgen nears deal to acquire Horizon Therapeutics, WSJ reports 01/30/23 U.S. considers cutting off Huawei fully from U.S. suppliers, Bloomberg says 01/30/23 U.S. considers cutting off Huawei fully from U.S. suppliers, Bloomberg says 01/11/23 TSMC receives 3nm chip orders from Broadcom, DigiTimes reports 01/04/23 China pauses chip industry investments as COVID resurges, Bloomberg reports 12/19/22 Hershey among brands called out by Consumer Reports for lead exposure 12/01/22 Twitter offers advertisers big incentives to boost spending, WSJ reports 11/09/22 Mondelez tells Reuters it removed ads from Twitter amid hate speech concerns 11/03/22 General Mills, Mondelez, Pfizer halt Twitter advertising, WSJ reports 01/30/23 EA's 'Dead Space' top-selling physical game in U.K., GI.biz says 01/23/23 Nintendo's new 'Fire Emblem' top-selling physical game in U.K., GI.biz says 01/18/23 Video game sales fell 13% y/y in Europe in December, GI.biz says 01/11/23 Amazon Game Studios loses another key executive amid cutbacks, Bloomberg says 01/25/23 Feds to question Snapchat's role in fentanyl-laced pills sales, Bloomberg says 01/25/23 Hawley to introduce bill to implement nationwide ban on TikTok, Fox reports 01/08/23 Seattle public schools blame tech giants for social media harm, Reuters says 12/22/22 TikTok parent ByteDance says staff improperly accessed user data, WSJ says 01/19/23 Epic, Match antitrust case against Google goes to trial in November, TC says 11/19/22 Match Group stock has been knocked down, time to pick it up, Barron's says 11/12/22 Bumble shares haven't met their match, time to buy stock, Barron's says 10/11/22 Epic Games and Match expand antitrust allegations against Google, TC says 01/23/23 Western Digital, Kioxia progressing in merger talks, Bloomberg reports 01/04/23 Western Digital, Kioxia said to revive merger discussions, Bloomberg reports 01/04/23 Western Digital, Kioxia said to revive merger discussions, Bloomberg reports 09/22/22 Activist Elliott would like to see Pinterest put up for sale, Barron's says 08/27/22 Juniper Networks' AI strategy could push stock higher, Barron's says 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 What You Missed On Wall Street On Monday 01/28/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/27/23 Here's What You Missed in Crypto This Week 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 01/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/19/22 What You Missed On Wall Street On Monday 12/19/22 What You Missed On Wall Street This Morning 12/08/22 What You Missed On Wall Street On Thursday 10:08 Today Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/08/22 What You Missed On Wall Street On Thursday 12/08/22 What You Missed On Wall Street This Morning 12/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/24/23 What You Missed This Week in Video Games 01/17/23 What You Missed This Week in Video Games 01/10/23 What You Missed This Week in Video Games 01/03/23 What You Missed This Week in Video Games 11:13 Today Here's what Wall St. experts are saying about Snap ahead of earnings 01/25/23 #SocialStocks: Musk refutes veracity of WSJ story that he seeks $3B in funding 01/18/23 #SocialStocks: Meta fights scraping, Twitter interest payments coming due 01/17/23 What You Missed On Wall Street On Tuesday 01/26/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/02/22 What You Missed On Wall Street On Wednesday 11/02/22 What You Missed On Wall Street This Morning 01/23/23 What You Missed On Wall Street On Monday 01/23/23 What You Missed On Wall Street This Morning 01/05/23 What You Missed On Wall Street On Thursday 01/05/23 What You Missed On Wall Street This Morning 10/25/22 Fly Intel: After-Hours Movers 08/17/22 Here's what Wall Street experts are saying about Cisco ahead of earnings 10/11/22 Early notable gainers among liquid option names on October 11th 13:04 Today Advanced Micro options imply 7.0% move in share price post-earnings 01/24/23 Unusually active option classes on open January 24th 01/23/23 Early notable gainers among liquid option names on January 23rd 01/09/23 Early notable gainers among liquid option names on January 9th 01/26/23 Mondelez call volume above normal and directionally bullish 01/18/23 Mondelez call volume above normal and directionally bullish 11/28/22 Mondelez put volume heavy and directionally bearish 12/05/22 Edwards Lifesciences call volume above normal and directionally bullish 10/31/22 Early notable gainers among liquid option names on October 31st 10/27/22 Edwards Lifesciences options imply 4.1% move in share price post-earnings 10/12/22 Early notable gainers among liquid option names on October 12th 10/05/22 Electronic Arts put volume heavy and directionally bearish 10/03/22 Electronic Arts Inc. call volume above normal and directionally bullish 08/26/22 Early notable gainers among liquid option names on August 26th 08/26/22 Unusually active option classes on open August 26th 13:19 Today Snap Inc. options imply 18.8% move in share price post-earnings 12/22/22 Snap Inc. call volume above normal and directionally bullish 12/15/22 Snap Inc. call volume above normal and directionally bullish 12/14/22 Snap Inc. call volume above normal and directionally bullish 01/09/23 Early notable gainers among liquid option names on January 9th 12/13/22 Early notable gainers among liquid option names on December 13th 11/15/22 Early notable gainers among liquid option names on November 15th 11/02/22 Early notable gainers among liquid option names on November 2nd 01/27/23 Unusually active option classes on open January 27th 01/23/23 Early notable gainers among liquid option names on January 23rd 01/09/23 Western Digital put volume heavy and directionally bearish 01/05/23 Early notable gainers among liquid option names on January 5th
Recommendations
Show Hide Related Items >> <<
01/30/23 Regeneron, Sanofi announce EC expansion of Dupixent marketing authorization 01/27/23 Regeneron, Sanofi announce CHMP opinion recommending EU approval for Dupixent 01/25/23 Denali Therapeutics announces achievement of RIPK1 milestone for Phase 2 trial 01/25/23 Innate Pharma announces HSR clearance for Sanofi collaboration expansion 12/21/22 Barclays Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays 12/16/22 Goldman Sachs Sanofi reinstated with a Buy at Goldman Sachs 12/15/22 Guggenheim Vaxcyte initiated with a Buy at Guggenheim on pneumococcal vaccine potential 12/14/22 UBS Sanofi price target raised to EUR 97 from EUR 92 at UBS 10/28/22 Sanofi now sees 2022 business EPS growing 16% at CER 10/28/22 Sanofi reports Q3 business EPS EUR 2.88, up 17.9% at CER 01/30/23 Sanofi plans to lay off staff at vaccine factories in India, Reuters says 01/23/23 CytoReason to license IBD disease model to Sanofi 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 12/24/22 Pfizer, Moderna among vaccine makers to watch in 2023, Barron's says 12/21/22 Biotech Alert: Searches spiking for these stocks today 11/30/22 What You Missed On Wall Street On Wednesday 11/30/22 What You Missed On Wall Street This Morning 11/30/22 Fly Intel: Pre-market Movers 11/11/22 Sanofi put volume heavy and directionally bearish 10/11/22 Sanofi put volume heavy and directionally bearish 09/26/22 Largest borrow rate increases among liquid names
Recommendations
Wells Fargo analyst Larry…
Show Hide Related Items >> <<
01/30/23 Johnson & Johnson falls after court rejects bankruptcy plan for talc lawsuits 01/30/23 J&J drops 3% after court rejects bankruptcy plan for talc lawsuits 01/27/23 Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI 01/24/23 Johnson & Johnson says assuming a lot of inflationary carryover in 2023 08:18 Today BofA J&J talc bankruptcy case dismissal impact to be determined, says BofA 01/27/23 BTIG BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal 01/27/23 Piper Sandler Piper keeps $78 target on Legend Biotech after Carvykti trial hits 01/25/23 JMP Securities J&J conference call comments 'a good sign' for Protagonist, says JMP Securities 01/30/23 Johnson & Johnson to challenge federal appeals court ruling 01/24/23 Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33 01/24/23 Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60 01/24/23 Johnson & Johnson sees FY23 adjusted operation EPS $10.50, consensus $10.33 01/30/23 Appeals court dismisses Chapter 11 case of J&J unit, WSJ reports 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/09/23 J&J may look for deals that boost eye care, surgical robots units, Reuters says 12/04/22 J&J says won't make offer for Horizon Therapeutics, Bloomberg reports 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 08:00 Today Johnson & Johnson put buyer realizes 135% same-day gains 01/30/23 Johnson & Johnson put volume heavy and directionally bearish 01/24/23 Unusually active option classes on open January 24th 01/20/23 Johnson & Johnson put buyer realizes 33% same-day gains
Recommendations
Show Hide Related Items >> <<
01/30/23 Johnson & Johnson falls after court rejects bankruptcy plan for talc lawsuits 01/30/23 J&J drops 3% after court rejects bankruptcy plan for talc lawsuits 01/27/23 Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI 01/24/23 Johnson & Johnson says assuming a lot of inflationary carryover in 2023 01/27/23 BTIG BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal 01/27/23 Piper Sandler Piper keeps $78 target on Legend Biotech after Carvykti trial hits 01/25/23 JMP Securities J&J conference call comments 'a good sign' for Protagonist, says JMP Securities 01/24/23 H.C. Wainwright Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright 01/30/23 Johnson & Johnson to challenge federal appeals court ruling 01/24/23 Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33 01/24/23 Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60 01/24/23 Johnson & Johnson sees FY23 adjusted operation EPS $10.50, consensus $10.33 01/30/23 Appeals court dismisses Chapter 11 case of J&J unit, WSJ reports 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/09/23 J&J may look for deals that boost eye care, surgical robots units, Reuters says 12/04/22 J&J says won't make offer for Horizon Therapeutics, Bloomberg reports 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 08:00 Today Johnson & Johnson put buyer realizes 135% same-day gains 01/30/23 Johnson & Johnson put volume heavy and directionally bearish 01/24/23 Unusually active option classes on open January 24th 01/20/23 Johnson & Johnson put buyer realizes 33% same-day gains
Options
Show Hide Related Items >> <<
01/30/23 Johnson & Johnson falls after court rejects bankruptcy plan for talc lawsuits 01/30/23 J&J drops 3% after court rejects bankruptcy plan for talc lawsuits 01/27/23 Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI 01/24/23 Johnson & Johnson says assuming a lot of inflationary carryover in 2023 01/27/23 BTIG BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal 01/27/23 Piper Sandler Piper keeps $78 target on Legend Biotech after Carvykti trial hits 01/25/23 JMP Securities J&J conference call comments 'a good sign' for Protagonist, says JMP Securities 01/24/23 H.C. Wainwright Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright 01/30/23 Johnson & Johnson to challenge federal appeals court ruling 01/24/23 Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33 01/24/23 Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60 01/24/23 Johnson & Johnson sees FY23 adjusted operation EPS $10.50, consensus $10.33 01/30/23 Appeals court dismisses Chapter 11 case of J&J unit, WSJ reports 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/09/23 J&J may look for deals that boost eye care, surgical robots units, Reuters says 12/04/22 J&J says won't make offer for Horizon Therapeutics, Bloomberg reports 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 01/30/23 Johnson & Johnson put volume heavy and directionally bearish 01/24/23 Unusually active option classes on open January 24th 01/20/23 Johnson & Johnson put buyer realizes 33% same-day gains 01/11/23 Unusually active option classes on open January 11th
Periodicals
Show Hide Related Items >> <<
06:18 Today Amgen announces Humira biosimilar now available in the U.S. 01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 01/03/23 Researchers' reanalysis questions mortality data in FOURIER trial 12/13/22 Amgen announces presentation of results from E1910 randomized Phase 3 trial 01/10/23 AbbVie and Anima Biotech collaborate for mRNA modulators discovery 01/06/23 AbbVie, Immunome enter collaboration to discover novel antibody-target pairs 01/06/23 AbbVie, Immunome announce strategic collaboration 12/21/22 Washington state AG files lawsuits against pharmacy chains over opioid crisis 01/26/23 JPMorgan AbbVie recent weakness a buying opportunity, says JPMorgan 01/05/23 Truist AbbVie price target raised to $180 from $160 at Truist 11/17/22 Credit Suisse AbbVie initiated with an Outperform at Credit Suisse 11/08/22 Societe Generale AbbVie downgraded at Societe Generale on blood cancer and aesthetics headwinds 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/03/23 Barclays Research raises 'valid questions' about Amgen's Repatha, says Barclays 12/13/22 BMO Capital Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital 12/13/22 Baird Amgen deal yields nice accretion but large debt position, says Baird 11/03/22 Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00 11/03/22 Amgen reports Q3 adjusted EPS $4.70, consensus $4.44 11/03/22 Notable companies reporting after market close 08/04/22 Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40 11/08/22 Caribou Biosciences reports Q3 revenue $3.3M, consensus $3.7M 10/28/22 AbbVie sees FY22 revenue approximately $58.2B, consensus $59.92B 10/28/22 AbbVie sees Q4 adjusted EPS $3.65-$3.69, consensus $3.75 10/28/22 AbbVie narrows FY22 adjusted EPS view to $13.84-$13.88 from $13.76-$13.96 01/30/23 Amgen lays off 300 employees, or 1.2% of workforce, Reuters reports 01/26/23 Warren writes FTC over concerns of two pharma deals, Reuters reports 12/11/22 Amgen nears deal to acquire Horizon Therapeutics, WSJ reports 11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 What You Missed On Wall Street On Monday 12/15/22 What You Missed On Wall Street On Thursday 12/15/22 What You Missed On Wall Street This Morning 12/05/22 What You Missed On Wall Street This Morning 11/21/22 Biotech Alert: Searches spiking for these stocks today 10/11/22 Early notable gainers among liquid option names on October 11th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th 08/19/22 Unusually active option classes on open August 19th
Hot Stocks
Amgen announced Amjevita,…
Show Hide Related Items >> <<
01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 01/03/23 Researchers' reanalysis questions mortality data in FOURIER trial 12/13/22 Amgen announces presentation of results from E1910 randomized Phase 3 trial 12/12/22 Amgen raises quarterly dividend by 10% to $2.13 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/03/23 Barclays Research raises 'valid questions' about Amgen's Repatha, says Barclays 12/13/22 BMO Capital Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital 12/13/22 Baird Amgen deal yields nice accretion but large debt position, says Baird 11/03/22 Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00 11/03/22 Amgen reports Q3 adjusted EPS $4.70, consensus $4.44 11/03/22 Notable companies reporting after market close 08/04/22 Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40 01/30/23 Amgen lays off 300 employees, or 1.2% of workforce, Reuters reports 01/26/23 Warren writes FTC over concerns of two pharma deals, Reuters reports 12/11/22 Amgen nears deal to acquire Horizon Therapeutics, WSJ reports 11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 What You Missed On Wall Street On Monday 10/11/22 Early notable gainers among liquid option names on October 11th
